Cellares Raises $255M Series C To Launch First Integrated Development And Manufacturing Organization (Idmo) And Pioneering Smart Factory To Meet Global Demand For Life-Saving Cell Therapies
Amount Raised
$255 Million
Round Type
Series C
South San FranciscoManufacturingBiotechnologyInvestors
Description
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the financing, David Mauney, Managing Director at Koch Disruptive Technologies, will join the company's board of directors. Global biopharmaceutical company and cell therapy leader Bristol Myers Squibb also participated in the round, alongside DFJ Growth, Willett Advisors and existing investors Eclipse, Decheng Capital, and 8VC.
Quick answer
Cellares raised $255 Million in a Series C round, dated August 23, 2023. Investors: Decheng Capital, Eclipse, Willett Advisors, DFJ Growth, Bristol Myers Squibb, David Mauney, Integrated and 8VC. Cellares is based in South San Francisco, California, United States.
- How much did Cellares raise?
- Cellares raised $255 Million in a Series C round on August 23, 2023.
- Who invested in Cellares?
- Decheng Capital, Eclipse, Willett Advisors, DFJ Growth, Bristol Myers Squibb, David Mauney, Integrated and 8VC are named as investors in this round.
- What does Cellares do?
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.
- Where is Cellares based and how big is it?
- Cellares is based in South San Francisco, California, United States. Fundz records about 300 employees.
- Who are the decision-makers at Cellares?
- Fundz holds 1 contact at Cellares, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Cellares that raised within 45 days of this round, from Fundz verified event records.
- MECAWARE raised $42M (Funding Round) on October 6, 2023.
- Endovia Health Sciences, Inc. raised $1.3M (Seed) on October 5, 2023.
- Experic raised an undisclosed amount (Series B) on October 5, 2023.
- FlexSea raised $2.4M (Seed) on October 4, 2023.
- Aurora Cannabis raised $31M (Funding Round) on October 3, 2023.
- Trautec raised an undisclosed amount (Series B) on September 28, 2023.
Who to call at Cellares, and when
A new round usually means Cellares is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cellares raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cellares, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cellares. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cellares raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cellares raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.